We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Almac Partners with Merck KGaA and the MRC to Assess Markers of Response to Cetuximab Therapy

News   Apr 15, 2010

 
Almac Partners with Merck KGaA and the MRC to Assess Markers of Response to Cetuximab Therapy
 
 
 

RELATED ARTICLES

Should You Eat a Low-gluten Diet?

News

When healthy people eat a reduced-gluten and fiber-rich diet they experience less intestinal discomfort and bloating but this is more likely due to a change in composition of dietary fibers than gluten itself.

READ MORE

Identifying Alzheimer's Drug Candidates with Anti-aging Properties

News

Old age is the greatest risk factor for many diseases, including Alzheimer's disease (AD) and cancer. Geroprotectors are a recently identified class of anti-aging compounds. New research has now identified a unique subclass of these compounds, dubbed geroneuroprotectors (GNPs), which are AD drug candidates and slow the aging process in mice.

READ MORE

Drug Reduces Menstrual Bleeding for Women with Gynecologic Tumors

News

A new oral drug significantly reduced menstrual bleeding for women with the most common gynecologic tumors in the United States - benign tumors that disproportionately affect African-Americans, an international clinical trial found.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE